Study Stopped
Safety point reached, subjects in the 3D CT overlay group received sugnificantly less contrast.
Randomized Comparison Between 3 D CT Overlay and Conventional Fluoroscopy to Decrease Contrast and Radiation Exposure During Cryoballoon Ablation for Atrial Fibrillation
CAFE
2 other identifiers
interventional
30
1 country
1
Brief Summary
Cryoablation using a balloon is an effective therapy for paroxysmal atrial fibrillation (AF), however associated with significant amounts of radiation exposure and contrast medium use. A new imaging technique (3D CT overlay) could reduce radiation exposure and contrast medium use significantly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Aug 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 22, 2024
CompletedNovember 22, 2024
November 1, 2024
1.7 years
November 20, 2024
November 20, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Fluoroscopy time
To compare the fluoroscopy time between cryoballoon ablation with and without the use of 3D CT overlay
Procedure time
radiation exposure
To compare the radiation exposure (DAP) between cryoballoon ablation with and without the use of 3D CT overlay
Procedure time
Contrast
To compare the amount of contrast medium between cryoballoon ablation with and without the use of 3D CT overlay
Amount of contrast during procedure
Secondary Outcomes (1)
Recurrence
one year
Study Arms (2)
Standard fluorscopy
ACTIVE COMPARATORCryoablation using a balloon with standard fluoroscopy
3D CT overlay
EXPERIMENTALCryoablation using a balloon with 3D CT overlay
Interventions
Eligibility Criteria
You may qualify if:
- \- All patients screened are accepted for PVI according to the current guidelines - Patients are candidates for enrolment if they have paroxysmal AF as defined in the guidelines
You may not qualify if:
- Persistent, long-standing persistent or permanent AF
- Left atrial diameter \> 50 mm (measured in the parasternal long axis, as assessed with transthoracic echocardiography)
- Previous PVI ablation (epicardial or endocardial).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medisch Spectrum Twente
Enschede, Overijssel, 7500, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jurren van Opstal, MD, PhD
Medisch Spectrum Twente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- cardiologist
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 22, 2024
Study Start
August 1, 2012
Primary Completion
May 1, 2014
Study Completion
May 1, 2015
Last Updated
November 22, 2024
Record last verified: 2024-11